These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7797076)

  • 1. Dissection of progesterone receptor-mediated chromatin remodeling and transcriptional activation in vivo.
    Mymryk JS; Archer TK
    Genes Dev; 1995 Jun; 9(11):1366-76. PubMed ID: 7797076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-specific dynamics of the progesterone receptor in living cells and during chromatin remodeling in vitro.
    Rayasam GV; Elbi C; Walker DA; Wolford R; Fletcher TM; Edwards DP; Hager GL
    Mol Cell Biol; 2005 Mar; 25(6):2406-18. PubMed ID: 15743833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation.
    Gass EK; Leonhardt SA; Nordeen SK; Edwards DP
    Endocrinology; 1998 Apr; 139(4):1905-19. PubMed ID: 9528977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid hormone receptor status defines the MMTV promoter chromatin structure in vivo.
    Archer TK; Fryer CJ; Lee HL; Zaniewski E; Liang T; Mymryk JS
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):421-9. PubMed ID: 7626491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activation of the IkappaBalpha and mouse mammary tumor virus promoters by progesterone and glucocorticoid receptors.
    Deroo BJ; Archer TK
    J Steroid Biochem Mol Biol; 2002 Aug; 81(4-5):309-17. PubMed ID: 12361720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hormone antagonists on chromatin remodeling and transcription factor binding to the mouse mammary tumor virus promoter in vivo.
    Mymryk JS; Archer TK
    Mol Endocrinol; 1995 Dec; 9(12):1825-34. PubMed ID: 8614418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mouse mammary tumor virus promoter adopts distinct chromatin structures in human breast cancer cells with and without glucocorticoid receptor.
    Kinyamu HK; Fryer CJ; Horwitz KB; Archer TK
    J Biol Chem; 2000 Jun; 275(26):20061-8. PubMed ID: 10751396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two types of anti-progestins have distinct effects on site-specific phosphorylation of human progesterone receptor.
    Beck CA; Zhang Y; Weigel NL; Edwards DP
    J Biol Chem; 1996 Jan; 271(2):1209-17. PubMed ID: 8557652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse mammary tumor virus chromatin in human breast cancer cells is constitutively hypersensitive and exhibits steroid hormone-independent loading of transcription factors in vivo.
    Mymryk JS; Berard D; Hager GL; Archer TK
    Mol Cell Biol; 1995 Jan; 15(1):26-34. PubMed ID: 7799933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells.
    Hurd C; Nag K; Khattree N; Alban P; Dinda S; Moudgil VK
    Mol Cell Biochem; 1999 Sep; 199(1-2):49-56. PubMed ID: 10544951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complex role of histone H1 in transactivation of MMTV promoter chromatin by progesterone receptor.
    Vicent GP; Koop R; Beato M
    J Steroid Biochem Mol Biol; 2002 Dec; 83(1-5):15-23. PubMed ID: 12650697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone receptor and the mechanism of action of progesterone antagonists.
    Edwards DP; Altmann M; DeMarzo A; Zhang Y; Weigel NL; Beck CA
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):449-58. PubMed ID: 7626494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of transiently and constitutively expressed progesterone receptors: evidence for two functional states.
    Smith CL; Wolford RG; O'Neill TB; Hager GL
    Mol Endocrinol; 2000 Jul; 14(7):956-71. PubMed ID: 10894147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways.
    Beck CA; Weigel NL; Moyer ML; Nordeen SK; Edwards DP
    Proc Natl Acad Sci U S A; 1993 May; 90(10):4441-5. PubMed ID: 8389450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of ligand binding, DNA binding and phosphorylation of progesterone receptor by two novel progesterone receptor antagonist ligands.
    Hurd C; Underwood B; Herman M; Iwasaki K; Kloosterboer HJ; Dinda S; Moudgil VK
    Mol Cell Biochem; 1997 Oct; 175(1-2):205-12. PubMed ID: 9350053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The differential capacity of glucocorticoids and progestins to alter chromatin structure and induce gene expression in human breast cancer cells.
    Archer TK; Zaniewski E; Moyer ML; Nordeen SK
    Mol Endocrinol; 1994 Sep; 8(9):1154-62. PubMed ID: 7838148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonist-occupied human progesterone receptors bound to DNA are functionally switched to transcriptional agonists by cAMP.
    Sartorius CA; Tung L; Takimoto GS; Horwitz KB
    J Biol Chem; 1993 May; 268(13):9262-6. PubMed ID: 8387487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
    Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
    Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New T47D breast cancer cell lines for the independent study of progesterone B- and A-receptors: only antiprogestin-occupied B-receptors are switched to transcriptional agonists by cAMP.
    Sartorius CA; Groshong SD; Miller LA; Powell RL; Tung L; Takimoto GS; Horwitz KB
    Cancer Res; 1994 Jul; 54(14):3868-77. PubMed ID: 8033109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor.
    Meyer ME; Pornon A; Ji JW; Bocquel MT; Chambon P; Gronemeyer H
    EMBO J; 1990 Dec; 9(12):3923-32. PubMed ID: 2249658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.